Clinical trialNCT06694805RecruitingPhase 3Interventional

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

SponsorViiV HealthcareEnrollment332HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Veronica Lacal Ridilenir
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Sebastian Nunez
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Pedro Cahn
Recruiting
Gsk Investigational Site
Capital Federal, Argentina
Marisa Sanchez
Recruiting
Gsk Investigational Site
Ciudad Autonoma de Bueno, Argentina
Eliana Loiza
Recruiting
Gsk Investigational Site
Córdoba, Argentina
Marcelo Martins
Recruiting
Gsk Investigational Site
Rosario, Argentina
Sergio Lupo
Recruiting

Belgium

Gsk Investigational Site
Antwerp, Belgium
Chris Kenyon
Recruiting

Canada

Gsk Investigational Site
Ottawa, Ontario, Canada
Withdrawn
Gsk Investigational Site
Montreal, Quebec, Canada
Nadine Kronfli
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Completed

Germany

Gsk Investigational Site
Cologne, North Rhine-Westphalia, Germany
Stefan Scholten
Recruiting
Gsk Investigational Site
Berlin, Germany
Stephan Grunwald
Recruiting
Gsk Investigational Site
Cologne, Germany
Christoph Wyen
Recruiting
Gsk Investigational Site
Düsseldorf, Germany
Bjoern-Erik Ole Jensen
Recruiting
Gsk Investigational Site
Frankfurt, Germany
Thomas Lutz
Recruiting

Italy

Gsk Investigational Site
Bari, Italy
Annalisa Saracino
Recruiting
Gsk Investigational Site
Bergamo, Italy
Diego Ripamonti
Recruiting
Gsk Investigational Site
Milan, Italy
Giulia Carla Marchetti
Recruiting
Gsk Investigational Site
Milan, Italy
Antonella Castagna
Recruiting
Gsk Investigational Site
Roma, Italy
Andrea Antinori
Recruiting

Portugal

Gsk Investigational Site
Porto, Portugal
Josefina Mendez
Recruiting
Gsk Investigational Site
Porto, Portugal
Rosario Serrao
Recruiting

Puerto Rico

Gsk Investigational Site
San Juan, Puerto Rico
Withdrawn

Spain

Gsk Investigational Site
Barcelona, Spain
roberto carlos guerri
Recruiting
Gsk Investigational Site
Barcelona, Spain
Maria Saumoy Linares
Recruiting
Gsk Investigational Site
Barcelona, Spain
Josep Mallolas Masferrer
Recruiting
Gsk Investigational Site
Barcelona, Spain
Paula Suanzes Díez
Recruiting
Gsk Investigational Site
Barcelona, Spain
Paula Prieto
Recruiting
Gsk Investigational Site
Bilbao, Spain
Sofía Ibarra Ugarte
Recruiting
Gsk Investigational Site
Cadiz, Spain
Alberto Romero Palacios
Recruiting
Gsk Investigational Site
Córdoba, Spain
Antonio Rivero
Recruiting
Gsk Investigational Site
Madrid, Spain
Cristina Diez Romero
Recruiting
Gsk Investigational Site
Madrid, Spain
Maria Jesus Perez Elias
Recruiting
Gsk Investigational Site
Madrid, Spain
Ignacio de los Santos Gil
Recruiting
Gsk Investigational Site
Madrid, Spain
Miguel Górgolas
Recruiting
Gsk Investigational Site
Madrid, Spain
María Luisa Montes Ramírez
Recruiting
Gsk Investigational Site
Madrid, Spain
Vicente Estrada
Recruiting
Gsk Investigational Site
Madrid, Spain
Guillermo Cuevas
Recruiting
Gsk Investigational Site
Madrid, Spain
María de Lagarde Sebastián
Recruiting

49 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Dec 2024
Primary completion: 19 Aug 2026
Completion: 18 Aug 2028
Last update posted: 27 May 2026
Registered enrollment: 332
Registry id: NCT06694805

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-515070-28-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.